- PENG Z, Yuan H, Huang J, Lin X, et al
A novel ursodeoxycholic acid derivative exhibits broad-spectrum antiviral activity against influenza A virus and coronaviruses by multiphasic disruption of the viral life cycle.
Antimicrob Agents Chemother. 2026 Sep 9:e0028426. doi: 10.1128/aac.00284.
PubMed Abstract available - BOZZOLA E, Piccotti E, D'Auria E, Trapani S, et al
RESPIRIAMO - Italian hospital surveillance for lower respiratory tract infections: a multicenter retrospective cohort study of respiratory syncytial virus-associated hospitalizations in children under 2 years of age.
BMC Pediatr. 2026;26:853.
PubMed Abstract available - ZHU X, Deng Y, Xiao G, Zhang J, et al
Re-emergence of H10N3 Avian Influenza Viruses in China: Evolutionary Dynamics and Emerging Zoonotic Risk.
J Infect. 2026 Sep 7:106848. doi: 10.1016/j.jinf.2026.106848.
PubMed - EZEANYAEGBU CN, Toledo NP, Corkum CP, Nelder M, et al
Evaluation of one-step amplicon-based targeted enrichment for SARS-CoV-2 whole-genome sequencing using the Midnight amplicon scheme.
J Virol Methods. 2026;346:115448.
PubMed Abstract available - KAZEMIAN S, Pedroza S, Santana-Pereira ALR, Neasham PJ, et al
An enhanced multisegment RT-PCR method for influenza A virus sequencing: Improved performance and reduced preparation time over traditional methods.
J Virol Methods. 2026;347:115453.
PubMed Abstract available - QUILTY BJ, Chapman LAC, Munday JD, Wong KLM, et al
Disentangling the drivers of heterogeneity in SARS-CoV-2 transmission from data on viral load and daily contact rates.
PLoS Comput Biol. 2026;22:e1014715.
PubMed Abstract available - SONG P, de Vlas SJ, Emery T, Coffeng LE, et al
Mapping spatial colleague connectivity patterns from individual-level registry data to inform regional pandemic interventions.
PLoS Comput Biol. 2026;22:e1014721.
PubMed Abstract available - PANT B, Lalovic M, Kiss IZ, Santillana M, et al
The paradox of neglecting changes in behavior: How standard epidemic models misestimate both transmissibility and final epidemic size.
PLoS Comput Biol. 2026;22:e1014746.
PubMed Abstract available - YUAN Z, Zhang X, Lin G, Zou Q, et al
AET5: A transcriptome-guided molecular generation framework with contrastive self-supervised learning.
PLoS Comput Biol. 2026;22:e1014703.
PubMed Abstract available - BENHAMOU W, Howerton E, Park SW, Viboud C, et al
Leveraging perturbations to infer the population dynamics of human rhinovirus and interaction of influenza A virus.
PLoS Comput Biol. 2026;22:e1014784.
PubMed Abstract available - LENGLART L, Titomanlio L, Alberti I, Almeida L, et al
Association between nirsevimab coverage and pediatric emergency department visits for bronchiolitis in 12 European countries: An interrupted time-series analysis.
PLoS Med. 2026;23:e1005223.
PubMed Abstract available - KWON K, Jang CY, Kim W, Son J, et al
Kinetics of the PASC Index in Long COVID.
PLoS One. 2026;21:e0357670.
PubMed Abstract available - BATTU S, Moore AR, Lebold K, Pacheco-Navarro A, et al
Outcomes of immunocompromised and non-immunocompromised patients in the ICU diverge late in the pandemic.
PLoS One. 2026;21:e0357181.
PubMed Abstract available - JI M, Dong H, Xu Y, Wang Y, et al
Development of a multiplex real-time PCR assay with fluorescence probe-melting-curve analysis for one-tube detection of respiratory pathogens.
PLoS One. 2026;21:e0357377.
PubMed Abstract available - GONG X, Liu L, Lu Y, Zhang G, et al
Sleepless in America: A social sensing study of pandemic-era sleeplessness using nighttime social media data.
PLoS One. 2026;21:e0356547.
PubMed Abstract available - BHATIA A, Elser J, Carrell SJ, Kronmiller B, et al
Correlation assessment of SARS-CoV-2 variants and their subvariants present in clinical and wastewater samples in Oregon, USA (February 7, 2021 - February 26, 2022) using the Freyja bioinformatics approach.
PLoS One. 2026;21:e0357591.
PubMed Abstract available - MOHD YUSOFF H, Yew SQ, Mohd Nawi A, Mohd Tohit N, et al
Prevalence and risk factors of adverse work outcomes among manufacturing workers with Long COVID in Malaysia - A nationwide study.
PLoS One. 2026;21:e0357125.
PubMed Abstract available - VALDES-LOPEZ JF, di Filippo D, Penagos S, Hernandez-Sarmiento LJ, et al
SARS-CoV-2 infection induces functional impairment of vitamin D receptor signaling to drive interleukin 6-dependent hyperinflammation in mononuclear phagocytes.
PLoS One. 2026;21:e0357030.
PubMed Abstract available - AMARSANAA J, Nguyen TXT, Khan MSR, Kadoya Y, et al
The dynamics of loneliness: A longitudinal exploration of transitions in Japan across the COVID-19 period, 2020-2024.
PLoS One. 2026;21:e0358269.
PubMed Abstract available - LI L, Nguyen L, Qu H, Wu Q, et al
Increased receptor binding and spike glycosylation, remodeled immune escape of surging SARS-CoV-2 subvariant BA.3.2.2/RE.2.2/Cicada.
Proc Natl Acad Sci U S A. 2026;123:e2614163123.
PubMed Abstract available - BUCKLIN R, Gauthreaux N, Faber E, Askelson N, et al
Listening to micropolitan community leaders to support pandemic response efforts.
Vaccine. 2025;60 Suppl 1:127255.
PubMed Abstract available - HOLLIDAY RC, Darkwa A, Brooks GA, Akintobi TH, et al
Developing counter-narratives to address COVID-19 misinformation among 18-24 year olds in community and campus settings.
Vaccine. 2025;60 Suppl 1:127135.
PubMed Abstract available - HEIMAN SL, Geiger N
Overestimation of racial ingroup worry about the COVID-19 vaccine and medical racism.
Vaccine. 2026;91:129046.
PubMed Abstract available - DUTTA S, Ngemera D, Jaillard P, Juneja S, et al
Lessons learnt from one-year cold chain support for COVID-19 vaccination in 5 middle income countries of North Africa.
Vaccine. 2026;91:128994.
PubMed Abstract available - CAMPBELL STATLER M, Bishop-Royse J, Sampson AT, Martin M, et al
Heterogeneity among the vaccine hesitant: A secondary analysis of the national CEAL Common Survey data.
Vaccine. 2026;91:129024.
PubMed Abstract available - KIM SJ, Kim HW, Son SE, Song JH, et al
Wuhan-ancestral multi-antigen SARS-CoV-2 virus-like particles protect against the omicron sublineage JN.1 variant.
Vaccine. 2026;91:129059.
PubMed Abstract available - FAHFOUHI Y, Fievez S, Cohen R, Levy C, et al
A health-economic assessment of the impact of different RSVpreF maternal vaccine strategies to prevent RSV infections among young infants, in France: EPIPACT.
Vaccine. 2026;91:129036.
PubMed Abstract available - BERIKOPOULOU MM, Tatsi EB, Siahanidou T, Michos A, et al
Systematic review of the mutations in the active antigenic site O of the prefusion F protein of the Respiratory Syncytial Virus (RSV) following the implementation of monoclonal antibody prophylaxis.
Vaccine. 2026;91:129069.
PubMed Abstract available - NUNES JPDS, Daher IP, Pires ADS, Yamamoto MM, et al
Synergistic effect of AddaS03 and poly I:C adjuvants on antibody titers and Th1-biased T cell responses following RBD vaccination in BALB/c mice.
Vaccine. 2026;91:129073.
PubMed Abstract available - MONOI A, Endo A, Kriznar M, Suzuki M, et al
Comparing the potential impacts of seasonal immunisation against year-round immunisation to prevent RSV infant hospitalisations in Japan: A modelling study.
Vaccine. 2026;91:129079.
PubMed Abstract available - SCHRARSTZHAUPT IN, Diaz-Quijano FA
Effectiveness of COVID-19 vaccination schedules against severe COVID-19 in children aged 6 months to 4 years in Brazil: A population-based cohort study (2023-2024).
Vaccine. 2026;91:129096.
PubMed Abstract available - ALAMI A, Lewis M, El-Chaar D, Walker M, et al
Maternal vaccination with RSVpreF and risk of hypertensive disorders of pregnancy: a systematic review and meta-analysis.
Vaccine. 2026;91:129070.
PubMed Abstract available - DENG L, Ye X, Chen X, Hu X, et al
Secretory expression of tetrameric neuraminidase enhanced by signal peptide optimization elicits robust immunity against influenza infection in mice.
Vaccine. 2026;92:129118.
PubMed Abstract available - SANBORN J, Robertson MM, Penrose K, Rane M, et al
Gaps between willingness and uptake of influenza and COVID-19 vaccines during the 2025-26 respiratory virus season in a U.S. adult cohort.
Vaccine. 2026;92:129126.
PubMed Abstract available - LU J, Ouyang Z, Huang F, Xie X, et al
Real-world effectiveness of the influenza vaccine among school-aged children in Shenzhen, China, 2024-2025 season: A test-negative design study.
Vaccine. 2026;92:129100.
PubMed Abstract available - THAKKAR V, Aryan Y, Gautam S, Joshi R, et al
Influence of vaccine delivery route on immune imprinting in influenza vaccination.
Vaccine. 2026;92:129109.
PubMed Abstract available - TORAIH EA, Hussein MH, Thomas SJ, Aiash H, et al
Cardiac outcomes following SARS-CoV-2 infection versus BNT162b2 vaccination in adolescents and young adults: a cohort study of 4 million individuals.
Vaccine. 2026;91:129001.
PubMed Abstract available - CABURNAY CA, Fu QJ, Carter T, Butler T, et al
Identification of best outreach strategies and delivery modalities for population subgroups for COVID-19 vaccination.
Vaccine. 2026;60 Suppl 1:128721.
PubMed Abstract available - CANACA G, Vicuna B, Hess JM, Cruz TH, et al
From engagement to ownership: a qualitative study of a community-academic partnership to promote COVID-19 vaccine confidence among Latino/Hispanic communities in New Mexico.
Vaccine. 2026;60 Suppl 1:128583.
PubMed Abstract available - STIEHL E, Negrete M, Flores G, Federmeyer L, et al
Empowering communities during the COVID-19 pandemic: insights from trusted messengers about their work addressing COVID-19 vaccine hesitancy.
Vaccine. 2026;60 Suppl 1:128559.
PubMed Abstract available - NUNO T, Soto S, Sepulveda R, Sierra LA, et al
The Arizona prevention research center vaccine confidence network: A Mobile health unit intervention and survey results of barriers and facilitators to COVID-19 vaccination.
Vaccine. 2025;60 Suppl 1:127970.
PubMed Abstract available - HARA-HUBBARD KK, Beaulieu A, Mendiola A, Gandhi P, et al
Strategies for addressing COVID-19 vaccine equity with intermediaries, prevention research centers, and the vaccine confidence network.
Vaccine. 2025;60 Suppl 1:127847.
PubMed Abstract available - CHUVILEVA YE, Kuiper NM, Ramakrishnan A, Goodman K, et al
Weaving a public health network: Process and results from an evaluation of CDC's Prevention Research Centers Vaccine Confidence Network.
Vaccine. 2025;60 Suppl 1:127636.
PubMed Abstract available - ALMUKHTAR S, McWhirter N, Mendiola A, Samuel S, et al
Exploring lingering COVID-19 vaccine hesitancy in three diverse U.S. states: Alabama, Illinois, and Texas.
Vaccine. 2025;60 Suppl 1:127664.
PubMed Abstract available - BEAULIEU A, LaMonaca K, Higginbottom J, Foster J, et al
Utilizing the Program Impact Pathways framework for improving COVID-19 vaccine confidence and uptake: demonstrations of multi-sector collaboration from two geographies in Connecticut.
Vaccine. 2025;60 Suppl 1:127623.
PubMed Abstract available - JEFFERS A, Kuiper NM, Ramakrishnan A, Swarna H, et al
Building trust in community-academic partnerships: Strategies for enhancing vaccine confidence and demand - Lessons from Prevention Research Centers.
Vaccine. 2025;60 Suppl 1:127624.
PubMed Abstract available - MCGEE RE, Barrett DA, Bednarczyk RA, Grant-Whitlock M, et al
Engaging rural and non-Hispanic Black persons in conversations about the COVID-19 vaccine: a process evaluation of a natural helper intervention.
Vaccine. 2025;60 Suppl 1:127587.
PubMed Abstract available - BORG A, Goulding M, Minkah P, Perrone D, et al
Promotion of COVID-19 vaccination for youth and families in Worcester, Massachusetts: a Diffusion of Innovations approach.
Vaccine. 2025;60 Suppl 1:127586.
PubMed Abstract available - SAVAS LS, Cuccaro P, Zhang K, Hernandez R, et al
Factors influencing COVID-19 vaccine uptake among vulnerable communities in Texas: Perceptions of 2-1-1 helpline callers.
Vaccine. 2025;60 Suppl 1:127554.
PubMed Abstract available - TOTZKAY D, Fraustino JD, Costello LM, Jarrett T, et al
Building on West Virginia's innovative COVID-19 public health communication: associations between vaccination beliefs and vaccination messaging, partisanship, and social vulnerability.
Vaccine. 2025;60 Suppl 1:127555.
PubMed Abstract available - O'CONNOR MH, Nyman AL, Ali S, Rothenberg R, et al
Increasing vaccine uptake in a refugee resettlement community with high social vulnerability.
Vaccine. 2025;60 Suppl 1:127552.
PubMed Abstract available - STIEHL E, Borg A, Cullen JP, Mendiola A, et al
Engaging trusted messengers in public health response: Key strategies to building community trust among CDC'S prevention research center's vaccine confidence network.
Vaccine. 2025;60 Suppl 1:127474.
PubMed Abstract available - HARA-HUBBARD KK, Flores Moreno MG, Sanchez M, Abdi N, et al
The partnership for vaccine confidence: community-academic partnerships to promote COVID-19 vaccines to underserved urban and rural communities using the listen, plan, act, evaluate process.
Vaccine. 2025;60 Suppl 1:127487.
PubMed Abstract available - MALLICK K, Handunge VL, Emmons KM, Blondet L, et al
Engaging a community health ambassador model to promote COVID-19 vaccine in three Massachusetts communities.
Vaccine. 2025;60 Suppl 1:127464.
PubMed Abstract available - ISHIGAKI H, Otaki K, Kitagawa N, Ishida H, et al
Pathogenicity of SARS-CoV-2 Omicron subvariants JN.1, EG.5.1, and BA.2.86.1 in immunologically naive cynomolgus macaques.
Virology. 2026;624:111036.
PubMed Abstract available - LIU Z, Fan M, Zheng Y, Zeng Y, et al
Transcriptome screening identifies circRNA-INSR as a novel host factor associated with avian influenza virus replication.
Virology. 2026;625:111072.
PubMed Abstract available - MILLER AK, Heremia L, Waller SJ, Blanchard SL, et al
Evaluating sampling strategies for the detection of avian influenza viruses in the environment.
Virology. 2026;625:111069.
PubMed Abstract available - ZHAO Y, Fan H
Clinical impact of baloxavir-induced PA I38T/M substitutions in diverse influenza populations: a systematic review and meta-analysis.
Virus Res. 2026;373:199797.
PubMed Abstract available
Antimicrob Agents Chemother
.jpg)
No comments:
Post a Comment